相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Novel CSF biomarkers for Alzheimer's disease and mild cognitive impairment
William T. Hu et al.
ACTA NEUROPATHOLOGICA (2010)
The FAS gene, brain volume, and disease progression in Alzheimer's disease
Deniz Erten-Lyons et al.
ALZHEIMERS & DEMENTIA (2010)
YKL-40: A Novel Prognostic Fluid Biomarker for Preclinical Alzheimer's Disease
Rebecca Craig-Schapiro et al.
BIOLOGICAL PSYCHIATRY (2010)
Alzheimer's beta-amyloid peptide blocks vascular endothelial growth factor mediated signaling via direct interaction with VEGFR-2
Nikunj S. Patel et al.
JOURNAL OF NEUROCHEMISTRY (2010)
Sparse partial least squares regression for simultaneous dimension reduction and variable selection
Hyonho Chun et al.
JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES B-STATISTICAL METHODOLOGY (2010)
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
Clifford R. Jack et al.
LANCET NEUROLOGY (2010)
The Role of Macrophage Migration Inhibitory Factor in Alzheimer's Disease
Michael Bacher et al.
MOLECULAR MEDICINE (2010)
Fibrinogen and β-Amyloid Association Alters Thrombosis and Fibrinolysis: A Possible Contributing Factor to Alzheimer's Disease
Marta Cortes-Canteli et al.
NEURON (2010)
Cerebrospinal fluid tau and ptau181 increase with cortical amyloid deposition in cognitively normal individuals: Implications for future clinical trials of Alzheimer's disease
Anne M. Fagan et al.
EMBO MOLECULAR MEDICINE (2009)
Vascular endothelial growth factor (VEGF) affects processing of amyloid precursor protein and β-amyloidogenesis in brain slice cultures derived from transgenic Tg2576 mouse brain
Susanne Buerger et al.
INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE (2009)
Increase of SCF plasma concentration during donepezil treatment of patients with early Alzheimer's disease
Thomas Leyhe et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2009)
Increased Plasma Urotensin-II and Carotid Atherosclerosis are Associated with Vascular Dementia
Yoshiyuki Ban et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2009)
Plasminogen activator activity is inhibited while neuroserpin is up-regulated in the Alzheimer disease brain
Shay Fabbro et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Macrophage migration inhibitory factor in mild cognitive impairment and Alzheimer's disease
Julius Popp et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2009)
VEGF genetic variability is associated with increased risk of developing Alzheimer's disease
Roberto Del Bo et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2009)
Multimodal techniques for diagnosis and prognosis of Alzheimer's disease
Richard J. Perrin et al.
NATURE (2009)
Biomarkers of Alzheimer's disease
Rebecca Craig-Schapiro et al.
NEUROBIOLOGY OF DISEASE (2009)
Relationships between biomarkers in aging and dementia
W. J. Jagust et al.
NEUROLOGY (2009)
Longitudinal Study of CSF Biomarkers in Patients with Alzheimer's Disease
Peder Buchhave et al.
PLOS ONE (2009)
Core candidate neurochemical and imaging biomarkers of Alzheimer's disease
Harald Hampel et al.
ALZHEIMERS & DEMENTIA (2008)
Age-related differences in NFκB translocation and Bcl-2/Bax ratio caused by TNFα and Abeta42 promote survival in middle-age neurons and death in old neurons
Jigisha R. Patel et al.
EXPERIMENTAL NEUROLOGY (2008)
Increasing CSF phospho-tau levels during cognitive decline and progression to dementia
Christin Andersson et al.
NEUROBIOLOGY OF AGING (2008)
Serum cystatin C and the risk of Alzheimer disease in elderly men
J. Sundelof et al.
NEUROLOGY (2008)
Plasma amyloid levels and the risk of AD in normal subjects in the Cardiovascular Health Study
O. L. Lopez et al.
NEUROLOGY (2008)
Cystatin C inhibits amyloid-β deposition in Alzheimer's disease mouse models
Weiqian Mi et al.
NATURE GENETICS (2007)
Cystatin C modulates cerebral β-amyloidosis
Stephan A. Kaeser et al.
NATURE GENETICS (2007)
Identification and validation of novel CSF biomarkers for early stages of Alzheimer's disease
Yan Hu et al.
PROTEOMICS CLINICAL APPLICATIONS (2007)
CSF tau/Aβ42 ratio for increased risk of mild cognitive impairment -: A follow-up study
G. Li et al.
NEUROLOGY (2007)
Fibrin deposition accelerates neurovascular damage and neuroinflammation in mouse models of Alzheimer's disease
Justin Paul et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Hemorheological mechanisms in Alzheimer's disease
Chia-Yu Chang et al.
MICROCIRCULATION (2007)
Ageing and amyloid-beta peptide deposition contribute to an impaired brain tissue plasminogen activator activity by different mechanisms
Mathias Cacquevel et al.
NEUROBIOLOGY OF DISEASE (2007)
Fibrinogen gamma-A chain precursor in CSF: a candidate biomarker for Alzheimer's disease
Joung Wook Lee et al.
BMC NEUROLOGY (2007)
Novel panel of cerebrospinal fluid biomarkers for the prediction of progression to Alzheimer dementia in patients with mild cognitive impairment
Anja H. Simonsen et al.
ARCHIVES OF NEUROLOGY (2007)
Cerebrospinal fluid tau/β-amyloid42 ratio as a prediction of cognitive decline in nondemented older adults
Anne M. Fagan et al.
ARCHIVES OF NEUROLOGY (2007)
Cerebrospinal fluid proteomic biomarkers for Alzheimer's disease
Erin J. Finehout et al.
ANNALS OF NEUROLOGY (2007)
Cystatin C reduces the in vitro formation of soluble A beta 1-42 oligomers and protofibrils
M. L. Selenica et al.
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION (2007)
A novel panel of cerebrospinal fluid biomarkers for the differential diagnosis of Alzheimer's disease versus normal aging and frontotemporal dementia
A. H. Simonsen et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2007)
Genotype and plasma concentration of cystatin C in patients with late-onset Alzheimer disease
Liang-Jen Chuo et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2007)
VEGF gene and phenotype relation with Alzheimer's disease and mild cognitive impairment
Martina Chiappelli et al.
REJUVENATION RESEARCH (2006)
[11]PIB in a nondemented population -: Potential antecedent marker of Alzheimer disease
M. A. Mintun et al.
NEUROLOGY (2006)
Longitudinal course and neuropathologic outcomes in original vs revised MCI and in pre-MCI
Martha Storandt et al.
NEUROLOGY (2006)
Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study
O Hansson et al.
LANCET NEUROLOGY (2006)
Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Aβ42 in humans
AM Fagan et al.
ANNALS OF NEUROLOGY (2006)
Measurement of thirteen biological markers in CSF of patients with Alzheimer's disease and other dementias
I Blasko et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2006)
Fibrinogen is associated with an increased risk of Alzheimer disease and vascular dementia
M van Oijen et al.
STROKE (2005)
Oxidative imbalance and cathepsin D changes as peripheral blood biomarkers of Alzheimer disease: A pilot study
E Straface et al.
FEBS LETTERS (2005)
Vascular endothelial growth factor gene variability is associated with increased risk for AD
R Del Bo et al.
ANNALS OF NEUROLOGY (2005)
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B
WE Klunk et al.
ANNALS OF NEUROLOGY (2004)
Binding of cystatin C to Alzheimer's amyloid β inhibits in vitro amyloid fibril formation
M Sastre et al.
NEUROBIOLOGY OF AGING (2004)
Chromogranin peptides in Alzheimer's disease
T Lechner et al.
EXPERIMENTAL GERONTOLOGY (2004)
Meningeal derived cerebrospinal fluid proteins in different forms of dementia: is a meningopathy involved in normal pressure hydrocephalus?
J Brettschneider et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2004)
Combining correlated diagnostic tests: Application to neuropathologic diagnosis of Alzheimer's disease
CJ Xiong et al.
MEDICAL DECISION MAKING (2004)
Proteomic studies of potential cerebrospinal fluid protein markers for Alzheimer's disease
M Puchades et al.
MOLECULAR BRAIN RESEARCH (2003)
CSF markers for incipient Alzheimer's disease
K Blennow et al.
LANCET NEUROLOGY (2003)
A panel of cerebrospinal fluid potential biomarkers for the diagnosis of Alzheimer's disease
O Carrette et al.
PROTEOMICS (2003)
Decreased β-amyloid1-42 and increased tau levels in cerebrospinal fluid of patients with Alzheimer disease
T Sunderland et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Fas and Fas Ligand are associated with neuritic degeneration in the AD brain and participate in β-amyloid-induced neuronal death
JH Su et al.
NEUROBIOLOGY OF DISEASE (2003)
The induction of the TNFα death domain signaling pathway in Alzheimer's disease brain
M Zhao et al.
NEUROCHEMICAL RESEARCH (2003)
Class prediction by nearest shrunken centroids, with applications to DNA microarrays
R Tibshirani et al.
STATISTICAL SCIENCE (2003)
Metalloproteinase shedding of Fas ligand regulates β-amyloid neurotoxicity
DW Ethell et al.
CURRENT BIOLOGY (2002)
Proteome analysis of cerebrospinal fluid proteins in Alzheimer patients
P Davidsson et al.
NEUROREPORT (2002)
Increased intrathecal levels of the angiogenic factors VEGF and TGF-beta in Alzheimer's disease and vascular dementia
E Tarkowski et al.
NEUROBIOLOGY OF AGING (2002)
Accumulation of calbindin in cortical pyramidal cells with ageing; a putative protective mechanism which fails in Alzheimer's disease
JRT Greene et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2001)
Relationship of calbindin D28K-immunoreactive cells and neuropathological changes in the hippocampal formation of Alzheimer's disease
S Iritani et al.
NEUROPATHOLOGY (2001)
Local and systemic GM-CSF increase in Alzheimer's disease and vascular dementia
E Tarkowski et al.
ACTA NEUROLOGICA SCANDINAVICA (2001)
Increased cerebrospinal fluid Fas (Apo-1) levels in Alzheimer's disease -: Relationship with IL-6 concentrations
M Martínez et al.
BRAIN RESEARCH (2000)
Glutamine synthetase, hemoglobin α-chain, and macrophage migration inhibitory factor binding to amyloid β-protein:: their identification in rat brain by a novel affinity chromatography and in Alzheimer's disease brain by immunoprecipitation
R Oyama et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY (2000)
Serum and cerebrospinal fluid cystatin C levels in vascular and Alzheimer's dementia
J Kálmán et al.
ACTA NEUROLOGICA SCANDINAVICA (2000)
分享论文
